Test Price
2,800 AED✅ Home Collection Available
ALPL Gene Odontohypophosphatasia Genetic Test in UAE | 2800 AED | DHA Licensed Molecular Diagnostics
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% diagnostic sensitivity via ISO 9001:2015 accredited NGS full-gene sequencing with confirmatory Sanger validation.
- Premium Logistics: VIP mobile phlebotomy and temperature-controlled cold-chain home collection available daily from 8 AM to 11 PM across Dubai and all UAE emirates.
- Clinical Guidance: Complimentary telephonic post-test clinical interpretation session with a DHA-licensed Consultant Medical Geneticist.
- Insurance & Billing: Direct verification via WhatsApp at +971 54 548 8731.
- Turnaround Time: 3–4 weeks from sample collection to final molecular report.
Test Overview & Methodology
This advanced next-generation sequencing (NGS) panel interrogates the entire coding sequence of the ALPL gene, including intron-exon boundaries, to detect single nucleotide variants, small insertions and deletions, and copy number alterations causative of Odontohypophosphatasia (odonto-HPP). The test provides definitive molecular diagnosis, enabling differentiation from other metabolic bone disorders and precise carrier screening for at-risk family members.
| Feature | Our NGS Full-Gene Analysis | Targeted Sanger Sequencing |
|---|---|---|
| Diagnostic Sensitivity | 99.9% across all exons plus flanking intronic regions | ~95% restricted to known hotspot mutations only |
| Variant Detection Scope | Full gene sequencing with CNV detection (deletions/duplications) | Limited to single or few amplicons; large rearrangements missed |
| Turnaround Time | 3–4 weeks including cold-chain logistics and bioinformatic analysis | 2–3 weeks without home collection capability |
| Sample Flexibility | Whole blood, FTA card, or extracted genomic DNA accepted | Fresh EDTA whole blood mandatory |
| Accreditation & Guidelines | ISO 9001:2015, DHA licensed, AMP/ACMGG variant classification standards | Varies across laboratories; often lacks CAP-equivalent accreditation |
Physician Insight & Safety Protocols
“The ALPL NGS test offers high-resolution molecular evidence when Odontohypophosphatasia is suspected due to premature exfoliation of primary teeth, deficient cementum formation, or unexplained alveolar bone loss. A positive result supports early dental rehabilitation and family cascade screening; a negative result in the context of strong clinical suspicion should prompt evaluation of broader metabolic bone disorders. Always correlate molecular findings with serum alkaline phosphatase activity, dental radiographs, and the full clinical phenotype.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Critical Safety Advisory Before Sample Collection
Do not alter or discontinue any prescribed medications—including bisphosphonates, vitamin B6, or dental treatments—without explicit instruction from your referring physician.
Sample Collection Exclusion Criteria & Emergency Indicators
- Exclusion: Individuals unable to provide informed consent or those without a legally authorized guardian. Venipuncture is deferred for hemodynamically unstable patients presenting with active bleeding, shock, or acute cardiovascular compromise.
- Exclusion: Untreated coagulopathy with INR exceeding 2.0 unless written clearance from the treating hematologist or physician is obtained prior to draw.
- Emergency Indicator: Persistent bleeding, expanding hematoma, or severe arm pain after phlebotomy warrants immediate evaluation at the nearest emergency department.
- Emergency Indicator: New-onset dental subluxation or acute jaw pain must be assessed urgently by a dentist; the genetic test does not induce these symptoms but may unmask pre-existing skeletal fragility.
Patient FAQ & Clinical Guidance
1. What does the ALPL NGS test detect and how does it guide my dentist's treatment plan?
Answer: The test reads every protein-coding base of the ALPL gene to identify mutations responsible for Odontohypophosphatasia, a genetic condition characterized by early loss of primary teeth and defective cementum. Your dentist uses the molecular diagnosis to differentiate odonto-HPP from other developmental dental disorders, select appropriate prosthodontic interventions, and time preventive care before permanent tooth eruption is compromised.
2. Why does the test require 3–4 weeks, and is home blood collection safe for my child?
Answer: The 3–4 week turnaround accounts for DNA extraction, NGS library preparation, high-depth sequencing, bioinformatic variant filtering, mandatory Sanger confirmation, and clinical interpretation. Our pediatric phlebotomists hold DHA-compliant certification for infant and child draws, employing ultra-fine butterfly needles and validated cold-chain transport to maintain sample integrity from your home to the laboratory.
3. Will my insurance cover the 2800 AED cost, and how do I obtain a prescription?
Answer: Most major UAE health insurers reimburse genetic diagnostic tests for hereditary metabolic disorders when supported by a referral letter from a physician and pre-authorization from the network. Send your insurance card via WhatsApp to +971 54 548 8731 for instant eligibility verification. A tele-consultation with our DHA-licensed physician can generate the required medical justification within 24 hours if you do not have a current prescription.
4. What is the difference between a positive and a negative result in clinical context?
Answer: A positive result confirms a pathogenic or likely pathogenic variant in ALPL, establishing a molecular diagnosis of Odontohypophosphatasia and enabling targeted dental surveillance and family member screening. A negative result reduces the likelihood of odonto-HPP but does not exclude all metabolic bone diseases; your physician may recommend broader metabolic or genetic testing based on your clinical presentation, alkaline phosphatase levels, and imaging findings.
5. Can I request the test directly, or do I need a referring physician?
Answer: UAE regulations require a referral from a licensed physician or specialist for all genetic diagnostic tests. DNA Labs UAE offers a complimentary tele-consultation with a DHA-licensed medical geneticist to evaluate your clinical history and issue the necessary referral, ensuring compliance with Federal Decree-Law No. 4 of 2016 on Medical Liability.
UAE Regulatory & Data Privacy Adherence
Full Compliance with UAE Health Data and Privacy Frameworks
This genetic diagnostic service operates in strict adherence to Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All patient data—including genomic sequences, clinical history, and personally identifiable information—are encrypted at rest and in transit, accessed only by authorized personnel bound by contractual confidentiality, and never shared with third parties without explicit written consent. Clinical procedures and patient safety protocols conform to Federal Decree-Law No. 4 of 2016 on Medical Liability, guaranteeing your rights to informed consent, privacy, and the highest standard of diagnostic care.
Clinical & Logistical Metadata
| Test Name | ALPL Gene Odontohypophosphatasia Genetic Test (NGS Full-Gene Sequencing) |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3–4 weeks from sample collection |
| Sample Type / Matrix | Peripheral whole blood (EDTA), FTA card, or extracted genomic DNA; VIP mobile phlebotomy and temperature-controlled cold-chain home collection available daily from 8 AM to 11 PM |
| Methodology Used | Next-Generation Sequencing (NGS) with full gene coverage plus confirmatory Sanger validation and CNV analysis |
| ICD-10-CM Code | E83.39 (Hypophosphatasia) |
| LOINC Code | 94831-8 (ALPL gene mutation analysis in blood or tissue) |
| DHA Facility License & Laboratory Address | DHA Facility License Number: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | Corporate Lab: DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians